Karyopharm Therapeutics Inc. (KPTI) Social Stream
Karyopharm Therapeutics Inc (KPTI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KPTI.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
KPTI's average price target has moved down $10.48 over the prior 40 weeks.
Over the past 50 weeks, KPTI's average upside potential has been 156.99%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KPTI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 90 days, KPTI's average broker recommendation rating improved by 0.25.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Karyopharm Therapeutics Inc's variance in analysts' estimates is lower than -792.09% of them.
- In terms of how Karyopharm Therapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 836.91% of that group.
- KPTI has a greater average analyst price target than 228.9% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Karyopharm Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 556.1% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Karyopharm Therapeutics Inc are KNTE, KNSA, and KMPH.
Is KPTI a Buy, Hold or Sell? See the POWR Ratings now!